Cargando...
Advantages to the Use of Rodent Hepadnavirus Core Proteins as Vaccine Platforms
The hepatitis B core antigen (HBcAg) has been proposed as a useful particulate carrier platform for poorly immunogenic peptidic and carbohydrate B cell epitopes. However, biochemical and immunologic impediments have plagued this technology. Specifically, the “assembly” problem characterized by the l...
Gardado en:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2006
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1810237/ https://ncbi.nlm.nih.gov/pubmed/17178179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2006.11.013 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|